# Novaspira Biotherapeutics news releases

- **Website:** https://novaspirabio.com
- **Location:** Chatham, NJ
- **Releases:** 1
- **First release:** November 7, 2026
- **Most recent:** November 7, 2026
- **Categories:** Healthcare & Pharmaceuticals Industry
- **Web page:** https://www.connectively.us/news-releases/novaspira-biotherapeutics
- **RSS:** https://www.connectively.us/news-releases/novaspira-biotherapeutics/rss.xml

## Media contact

Company Contact  
info@novaspirabio.com

## Releases

### [Novaspira Biotherapeutics Reports Phase 1 Data for a Novel GPC3x4-1BB Bispecific in Late-Breaking Oral at SITC 2026](https://www.connectively.us/news-releases/novaspira-biotherapeutics-reports-phase-1-data-for-a-novel-gpc3x4-1bb-2)

November 7, 2026 · Healthcare & Pharmaceuticals Industry · CHATHAM, NJ, UNITED STATES

Chatham, NJ, November 7, 2026: Novaspira Biotherapeutics today announced the presentation of first-in-human clinical data for BOS-342 (NS-342), a novel GPC3 × 4-1BB bispecific immunotherapy, in patients with advanced hepatocellular carcinoma (HCC).
